FDA Inspection
Baxter CorporationBaxter Corporation – FDA Inspection, Sep 17, 2019
Record Details
This FDA Inspection record concerns Baxter Corporation, with an inspection on September 17, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 88a423b0-a56b-4ad6-9cc7-b7287886b885
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102280
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Baxter Corporation
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| July 30, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| April 8, 2010 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Baxter Corporation
- FDA Inspection 1259651 - 2025-01-31
- FDA Inspection 943637 - 2015-07-30
- FDA Inspection 659975 - 2010-04-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.